Scorpius BioManufacturing
Mammalian & Microbial Biologics Manufacturing / Analytical Testing – CDMO
Goals & Objectives
Scorpius BioManufacturing began as a CRO that built a clinical-scale facility to enter the biologics CDMO space. It needed rapid awareness of its unknown brand to support the necessary return-on-investment with its new mammalian / microbial plant in a growing Texas bio-hub.
Strategic Approach
That’s Nice worked with parent company, Nighthawk, and Scorpius leadership to build an impactful brand and a go-to-market strategy that centered on saturated exposure, including a DCAT Week launch event at New York’s Rainbow Room and a flood of digital content, social media, scientific thought leadership, and top-of-funnel lead generation.
Meeting & Exceeding KPIs
Qualified leads began coming in immediately at the DCAT Week launch event and in less than 12 months, Scorpius established a professional brand, gained strong market recognition, and over-delivered on its first-year sales goals.
